|
Status |
Public on Mar 02, 2021 |
Title |
Vascular fate in misidentified pluripotent-derived blood-brain-barrier endothelial cells rescued by transcriptional reprogramming |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Total RNA, greater than 100ng, from cultured cells was isolated in TRIzol L and purified using Qiagen RNeasy Mini Kit per manufacturer’s protocols. Agilent Technologies 2100 Bioanalyzer was used to assess the RNA quality. RNA libraries were prepared and multiplexed using Illumina TruSeq RNA Library Preparation Kit v2 (non-stranded and poly-A selection) and 10 nM of cDNA was used as the input for high-throughput sequencing via Illumina’s HiSeq 2500 platform, producing 50 bp paired end reads.
|
|
|
Overall design |
Cell samples were harvested from in vitro culture conditions and sequenced using Illumina HiSeq 2500
|
|
|
Contributor(s) |
Lu TM, Houghton S, Rafii S, Agalliu D, Redmond D, Lis R |
Citation(s) |
33542154 |
|
Submission date |
Mar 01, 2021 |
Last update date |
Mar 03, 2021 |
Contact name |
Tyler Lu |
E-mail(s) |
[email protected]
|
Phone |
9089383803
|
Organization name |
Weill Cornell Medicine
|
Street address |
1300 York Avenue
|
City |
New York |
State/province |
New York |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (12)
|
|
Relations |
BioProject |
PRJNA705668 |
SRA |
SRP308696 |